Advanced Medical Solutions Group plc
AMS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £110,769 | £109,535 | £67,986 | £63,122 |
| % Growth | 1.1% | 61.1% | 7.7% | – |
| Cost of Goods Sold | £51,515 | £60,392 | £31,091 | £28,635 |
| Gross Profit | £59,254 | £49,143 | £36,895 | £34,487 |
| % Margin | 53.5% | 44.9% | 54.3% | 54.6% |
| R&D Expenses | £6,593 | £0 | £4,022 | £3,217 |
| G&A Expenses | £47,266 | £47,374 | £32,583 | £25,862 |
| SG&A Expenses | £48,852 | £42,330 | £33,395 | £26,669 |
| Sales & Mktg Exp. | £1,586 | £1,536 | £812 | £807 |
| Other Operating Expenses | -£6,918 | £0 | -£4,465 | -£3,875 |
| Operating Expenses | £48,527 | £42,330 | £32,952 | £26,011 |
| Operating Income | £10,727 | £6,813 | £3,641 | £8,476 |
| % Margin | 9.7% | 6.2% | 5.4% | 13.4% |
| Other Income/Exp. Net | -£2,264 | -£2,685 | £2,054 | £913 |
| Pre-Tax Income | £8,463 | £4,128 | £5,695 | £9,389 |
| Tax Expense | £2,305 | £1,162 | £1,519 | £2,432 |
| Net Income | £6,205 | £2,966 | £4,176 | £6,957 |
| % Margin | 5.6% | 2.7% | 6.1% | 11% |
| EPS | 0.029 | 0.013 | 0.02 | 0.032 |
| % Growth | 115.7% | -31.3% | -39.8% | – |
| EPS Diluted | 0.028 | 0.013 | 0.019 | 0.032 |
| Weighted Avg Shares Out | 218,486 | 221,343 | 214,173 | 218,293 |
| Weighted Avg Shares Out Dil | 218,787 | 221,343 | 217,709 | 218,547 |
| Supplemental Information | – | – | – | – |
| Interest Income | £358 | £137 | £2,024 | £1,557 |
| Interest Expense | £2,622 | £3,285 | £272 | £644 |
| Depreciation & Amortization | £9,076 | £10,599 | £4,902 | £5,625 |
| EBITDA | £19,803 | £18,012 | £8,845 | £15,658 |
| % Margin | 17.9% | 16.4% | 13% | 24.8% |